(UroToday.com) Treatment for patients with advanced bladder cancer has had some significant advances in the past few years. For many years, platinum-based chemotherapy has been standard of care, with significantly better outcomes among those able to tolerate cisplatin-based therapy than those who are cisplatin-ineligible. Since 2016, there has been a proliferation of treatment approaches including immunotherapy and targeted therapy.